| Description of Property | Date Acquired | Cost or Other Basis | Prior Years' Depreciation | Computation Method | Rate / Life (# of years) |
Current Year's Depreciation Expense | Net Investment Income | Adjusted Net Income | Cost of Goods Sold Not Included |
|---|
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| ESPERION THERAPEUTICS INC COM | 596,200 | 520,000 |
| ZENITH EPIGENETICS CORP | 4,759 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| CLEARWATER CAPITAL PARTNERS FU | 75,371 | 80,005 | |
| SILVERPEAK LEGACY FUND III, LP | 66,811 | 31,537 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Administrative Fees | 11,359 | 11,359 | ||
| Bank Charges | 60 | 60 | ||
| K-1 Exp CLEARWATER CAPITAL PAR | 1,020 | 1,020 | ||
| K-1 Exp SILVERPEAK LEGACY FUND | 321 | 321 | ||
| State or Local Filing Fees | 25 | 25 |
| Description | Revenue And Expenses Per Books | Net Investment Income | Adjusted Net Income |
|---|---|---|---|
| K-1 Inc/Loss CLEARWATER CAPITAL PARTNERS FUND III, | -2,747 | -2,747 | |
| K-1 Inc/Loss SILVERPEAK LEGACY FUND III, LP | 34 | 95 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Investment Management Services | 1,195 | 1,195 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| 990-PF Estimated Tax for 2020 | 4,200 | |||
| 990-PF Excise Tax for 2019 | 2,960 |